Browsing by Subject "Heparin, low-molecular-weight"
Now showing items 1-1 of 1
-
(2006)Once drug patents expire, the health authorities can approve the registry of similar products. They must request to the manufacturer, the bibliographic background of the original product and the analytical results that ...